AGP Executive Report
Last update: 4 hours agoUzbekistan’s pharma surge: National Statistics Committee data shows large pharmaceutical enterprises produced about UZS 1.89 trillion in medicines and pharma products in the first four months of 2026—up 30% year-on-year—with Tashkent city driving roughly 63% of output. Health supply links to the region: Balkh Pharmaceutical Wholesalers Association signed $5m in deals with Uzbek companies to help cover Afghanistan’s medicine needs, with officials saying the agreements could meet 20%–50% of demand. Patient-care and access signals: A new US-Uzbekistan Business and Investment Council was discussed at TIIF 2026, aiming to turn investment plans into deliverable projects in strategically important sectors—an indirect boost for health-related infrastructure and services. Public health policy on pollution: Uzbekistan plans a 2026 vehicle scrappage and buyback system for cars older than 30 years to cut air pollution, offering cash or vouchers toward new domestically made vehicles. Banking stress for households: The Central Bank published a list of banks with the poorest complaint-handling records, using a complaints-to-client-share index—relevant for people managing healthcare and other costs.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
